XML 45 R32.htm IDEA: XBRL DOCUMENT
v3.21.1

EPS Calculation (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2021
Earnings Per Share [Abstract] |
Schedule of reconciliation of the earnings and shares used in calculating basic and diluted EPS | The following table presents a reconciliation of the earnings/(loss) and shares used in calculating basic and diluted earnings/(loss) per share for the three months ended March 31, 2021 and 2020:
|  | Three Months Ended March 31, |  |
(In Thousands, Except Per Share Amounts) |  | 2021 |  | 2020 |  |  |  |
Basic Earnings/(Loss) per Share: |  |  |  |  |  |  |  |
Net income/(loss) to common stockholders |  | $ | 85,522 |  |  | $ | (908,995) |  |  |  |  |
Dividends declared on preferred stock |  | (8,219) |  |  | (5,215) |  |  |  |  |
Dividends, dividend equivalents and undistributed earnings allocated to participating securities |  | (274) |  |  | — |  |  |  |  |
Net income/(loss) to common stockholders - basic |  | $ | 77,029 |  |  | $ | (914,210) |  |  |  |  |
Basic weighted average common shares outstanding |  | 451,135 |  |  | 452,979 |  |  |  |  |
Basic Earnings/(Loss) per Share |  | $ | 0.17 |  |  | $ | (2.02) |  |  |  |  |
Diluted Earnings/(Loss) per Share: |  |  |  |  |  |  |  |
Net income/(loss) to common stockholders - basic |  | $ | 77,029 |  |  | $ | (914,210) |  |  |  |  |
Interest expense on Convertible Senior Notes |  | 3,909 |  |  | — |  |  |  |  |
Net income/(loss) to common stockholders - diluted |  | $ | 80,938 |  |  | $ | (914,210) |  |  |  |  |
Basic weighted average common shares outstanding |  | 451,135 |  |  | 452,979 |  |  |  |  |
Effect of assumed conversion of Convertible Senior Notes to common shares |  | 28,920 |  |  | — |  |  |  |  |
Diluted weighted average common shares outstanding (1) |  | 480,055 |  |  | 452,979 |  |  |  |  |
Diluted Earnings/(Loss) per Share |  | $ | 0.17 |  |  | $ | (2.02) |  |  |  |  |
(1)At March 31, 2021, the Company had approximately 3.1 million equity instruments outstanding that were not included in the calculation of diluted EPS for the three months ended March 31, 2021, as their inclusion would have been anti-dilutive. These equity instruments reflect RSUs (based on current estimate of expected share settlement amount) with a weighted average grant date fair value of $4.87. These equity instruments may have a dilutive impact on future EPS.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration